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ABSTRACT
Recombinant adenoviruses have been widely used
for various applications, including protein expres-
sion and gene therapy. We herein report a new and
simple cloning approach to an efficient and robust
construction of recombinant adenoviral genomes
based on the mating-assisted genetically integrated
cloning (MAGIC) strategy. The production of recom-
binant adenovirus serotype 5-based vectors was
greatly facilitated by the use of the MAGIC proced-
ure and the development of the Adeasy
TM adenoviral
vector system. The recombinant adenoviral plasmid
can be generated by a direct and seamless substi-
tution, which replaces the stuff fragment in a full-
length adenoviral genome with the gene of interest
in a small plasmid in Escherichia coli. Recombinant
adenoviral plasmids can be rapidly constructed in
vivo by using the new method, without manipula-
tions of the large adenoviral genome. In contrast to
other traditional systems, it reduces the need for
multiple in vitro manipulations, such as endonuc-
lease cleavage, ligation and transformation, thus
achieving a higher efficiency with negligible back-
ground. This strategy has been proven to be suitable
for constructing an adenoviral cDNA expression lib-
rary. In summary, the new method is highly efficient,
technically less demanding and less labor-intensive
for constructing recombinant adenoviruses, which
will be beneficial for functional genomic and
proteomic researches in mammalian cells.
INTRODUCTION
Adenoviral vectors are a versatile tool in the investigations of
gene expression and regulation as well as gene therapy. Sev-
eral advantages of the use of the adenovirus have been
demonstrated. These include the inability of the adenovirus
to integrate into the genome of the target cells, its broad spec-
trum of applications in various cell types, its high expression
of the gene of interest, the ability to produce high titers of
recombinant viruses, and the ability to have gene transferred
independent of active cell division (1–7). More recently, with
the increasing application of novel RNA silencing techniques,
adenoviruses have been shown to be a powerful approach to
facilitating the expression of short-interfering RNA (5,8).
Over the years, many approaches have been developed for
the generation of recombinant adenoviruses, which can be
divided into two basic categories; direct plasmid construction
of recombinant adenoviral genome (9–13) or indirect con-
struction (14–17). The former involves the ligation of the
adenoviral genome with the DNA fragments of interest, and
the latter involves homologous recombination in mammalian
cells or in Escherichia coli. The direct methods are handi-
capped by the limitation of choices of suitable restriction
sites and the difﬁculty in the manipulation of the large aden-
oviral vector. On the other hand, the indirect methods utilize
two plasmids coding for the homologous recombinant
regions; one is a shuttle plasmid containing an expression
cassette, and the other is the large plasmid containing the
majority of the adenoviral genome. For example, the con-
struction of the recombinant adenovirus through Cre-lox has
been described in studies with mammalian cells and E.coli
(14,16). The major advantage of indirect construction is the
elimination of repeated rounds of plaque puriﬁcation.
Although both of these methods work, the generation of
recombinant adenoviruses is still limited by several factors,
including the low efﬁciency and difﬁculty in the screening
of homologous recombination, the need for time-consuming
plaque puriﬁcation, and the frequent contamination by wild-
type adenoviruses. Given that there are probably 25000 genes
present in human cells, these traditional methods do not meet
the increasing reqiurements for the post-genome research on
gene expression and regulation as well as the development
of novel gene therapy approaches especially for the
high-throughput generation of viruses required in proteomic
studies (13).
Considering the aforementioned drawbacks, we have now
developed a robust and scalable system to generate recombin-
ant adenoviruses based on a previously reported in vivo clon-
ing system called mating-assisted genetically integrated
cloning (MAGIC) (18). The newly developed MAGIC pro-
cedure utilizes bacterial mating to catalyze the transfer of a
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and a recipient plasmid in a separate bacterial strain (18).
Then the recombination between these plasmids can be
forced by inducing I-SceI to site-speciﬁc cleavage and the
red and gam recombinase to homologous recombination.
The donor strain contains the F factor (F0) transfer system,
a low-copy plasmid containing a transfer operon (tra) and a
cis-acting origin of transfer (oriT). When the oriT is ligated
into the donor plasmid, the modiﬁed F0 is able to efﬁciently
mobilize the donor plasmid, but not itself (18). A donor plas-
mid must also have a conditional origin of replication from
R6K, orig, which is required for the trans-activation of factor
p encoded by the gene pir1 or its relaxed copy-number con-
trol allele, pir1-116. Only the donor strain DH10b can
express pir1-116, so the donor plasmid will replicate only
in DH10b, but not in the recipient strain BUN21 that does
not have pir1-116 (18). After the bacteria are mixed, the pres-
ence of arabinose will induce the homing endonuclease I-SceI
to lyse the fragment of interest from the donor plasmid, and
cut down the stuff fragment from the recipient plasmid. In
addition, the plasmid pML300 contained in BUN21 will be
induced to express the red recombinase gene in the presence
of rhamnose. The cleavage of both the donor fragment and
the recipient plasmid greatly enhances recombination events
(18). The plasmid pML300 contains a temperature-sensitive
mutant derivative of the pSC102 origin of replication and
will not replicate when bacteria are grown at 42 C. In the pre-
sent study, we cultured the bacteria at 42 C in order to elim-
inate the plasmid pML300. In brief, the MAGIC procedure
only requires the simple mixing of bacterial strains, which
would signiﬁcantly save time, effort and expense. Therefore,
this method may have implications in high-throughput
recombinant DNA production for functional genomics stud-
ies, including the generation of recombinant adenoviruses.
Herein we report a novel approach to the generation of
recombinant adenovirus based on the MAGIC procedure
(18). This method utilizes site-speciﬁc and intensive recomb-
ination with random 50 bp regions of homology under red
and gam recombinase, integrating the fragment of interest
into the full-length adenovirus genome. It is rapid (taking
only 12–14 days to generate a recombinant adenovirus) and
is free of parental virus contamination. We have constructed
a novel donor vector pRTRA, in which the fragment of inter-
est is ﬂanked by two different 50 bp homology regions, H1
and H2, which in turn are ﬂanked with two separate I-SceI
sites. The novel recipient vector pAd-pheS also contains
two I-SceI-linked H1 and H2 sites (8,18). The recombination
events are efﬁciently regulated by a series of intensive ele-
ments: an intron-encoding rare endonuclease I-SceI is
induced by the sugar arabinose; and the red and gam recom-
binase is induced by the sugar rhamnose. Once the DNA frag-
ment of interest in the donor vector and the stuff fragment in
the recipient vector are both cut down by I-SceI, the recomb-
ination events mediated by the red and gam recombinase are
stimulated. The efﬁciency of transfer of the DNA fragment
of interest from pRTRA to pAd-pheS was shown to
be very high; the positive recombination efﬁciency can be as
high as 100%. This novel method can be used for the high-
throughput creation of recombinant adenoviruses, which
may be suitable for constructing an adenoviral cDNA expres-
sion library as demonstrated in the present study.
MATERIALS AND METHODS
Cell culture
The human embryonic kidney (HEK293) cells (Invitrogen)
were cultured in DMEM supplemented with 10% fetal calf
serum (FCS). The HEK293 cells constitutively expressed
Adeasy deleted E1 gene in-trans. Infective virus particles
were produced after these cells were transfected with E1-
deleted adenovirus vectors. After infection with the recom-
binant adenoviruses, the cells were maintained in DMEM
supplemented with 5% FCS.
Bacteria, plasmids and viral DNA
E.coli strains DH10b and BUN21 and the plasmid pML300
were kindly donated by Prof. Stephen J Elledge from the Har-
vard Medical School in Boston, (MA, USA) (18). DH10b was
used for generating the recombinant donor plasmid and
BUN21 was used for generating and propagating the recom-
binant adenoviral plasmids. The plasmid pML300 contained
in BUN21 carries the red and gam recombinase gene induced
by rhamnose, and is unable to replicate when the bacteria are
grown at 42 C (18). The plasmid MAGIC1 and the plasmid
1202 were also provided by Prof. Stephen J Elledge (18).
The adenovirus bone vector (pAdeasy) and pShuttle plasmid
were obtained from Stratagene (15). We constructed the
novel donor plasmid pRTRA (Figure 1), the recipient plasmid
pAd-pheS (full-length adenoviral genome), the plasmid pPic-
man and the plasmid pShuttle-cmv-red-sv40polA.
Cloning the foreign genes gfp and man into the
donor plasmid using restriction enzyme Bsu36I and
T4 DNA polymerase
The gfp gene was ampliﬁed from pEGFP-1 (Clontech) by
PCR. The forward primer was 50-TTACGATGGTGAGCA-
AGGGCGAGGA-30, and the reverse primer was 50-TGACT-
TACTTGTACAGCTCGTCCATGCC-30. The man gene was
ampliﬁed from pPic-man using the primers: ZL15F, 50-TTA-
CTGAAGCGCATACTGTGTCGCC-30 and ZL16R, 50-TG-
ACCGGATTCACTCAACGATTGG-30. The ampliﬁed frag-
ments were incubated with 0.5 U of T4 DNA polymerase
and 4 mM dGTP (TaKaRa) at 12 C for 45 min, as described
previously (19,20). For each gene, a total of 30 ng of treated
fragments and 1 ng of the Bsu36I-digested (CCTTAGG and
CCTGAGG) pRTRA were ligated with 5 U of T4 DNA
ligase  (TaKaRa) at 16 C for 12 h in 1 ml buffer. The gfp
gene and man gene were inserted into pRTRA to form the
plasmids pRTGA and pRTMA separately (Figure 2).
Modification of the donor plasmid
The fragment of chloramphenicol resistent gene was ampli-
ﬁed from pBT (Strategene) by PCR using the forward primer
[50-TTTGTCGACATAACTTCGTATAATGTATGCTATA-
CGAAGTTATACGGGGAGAGCCTGAGCAAAC (SalI and
34 bp loxP sites underlined)] and the reverse primer [50-
TTTGTGCACATAACTTCGTATAGCATACATTATACG-
AAGTTATCAGCATCACCCGACGCACTTT-30 (ApaLI, 34
bp loxP sites underlined)]. The PCR was performed at 95 C
for 5 min, followed by 25 cycles at 95 C for 45 s, 56 C for
45 s and 72 C for 1 min by using Thermo Hybrid PX2
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fragment cut by ApaLI and SalI was ligated into the
pRTRA vector (also cut by the same enzymes), resulting in
the recombinant plasmid pRTRC.
Generating the recombinant adenoviral
vector by MAGIC
The overall strategy developed is shown in Figure 3. E.coli
DH10b containing the donor vector pRTRA was grown in
Luria–Bertani (LB) broth containing ampicillin (100 mg/ml).
The recipient strain BUN21 containing the plasmid pML300
and the recipient plasmid pAd-pheS was grown in LB broth
containing spectinomycin (50 mg/ml), kanamycin (50 mg/ml)
and glucose (0.2% w/v) overnight. The recipient strain was
washed twice with 2 volume of LB broth the next day. The
donor and recipient strains were separately diluted to 1:25,
1:50, 1:100 or 1:200 with LB broth containing 0.2% w/v rham-
nose and grown at 30 C for 2 h to an A600 of 0.15 0.25, and
the donor and recipient strains were mixed to a ratio of 1:1
based on their A600 in the presence of 0.2% w/v L-arabinose.
The mixture was incubated at 37 Cf o r2hw i t h o u ts h a k i n g ,
and then for a further 2 h with shaking. The recombinant
culture was diluted at the ratio of 1:100, plated on the selec-
tive plates containing kanamycin (50 mg/ml), ampicillin
(100 mg/ml), 10 mM Cl-Phe and 0.2% w/v L-arabinose, and
ﬁnally incubated at 42 C overnight (18).
Production of recombinant adenoviruses and
proliferation
The recombinant adenoviral plasmids were ampliﬁed by
incubating the colony identiﬁed in 50 ml LB broth containing
kanamycin (50 mg/ml), ampicillin (100 mg/ml) and 0.2% w/v
arabinose. The culture was grown overnight at 37 C. The
maxiprep DNA was then prepared from the liquid culture
and digested in a sufﬁcient amount (5 mg of DNA) with
PacI. Subsequently, the buffer and the excess enzyme from
restriction reactions were removed by phenol extraction/
ethanol precipitation. The DNA was re-suspended in 50 ml
of sterile 0.1· TE buffer or dH2O, and then added to
HEK293 cells in the presence of Lipofectamine 2000 (Invitro-
gen). At 4 h post-transfection, the cells were incubated in 5 ml
DMEM containing 5% FCS. About 8 days after transfection,
(a) (b)
Figure 1. (a) Restriction map of the donor plasmid pRTRA, see the text for details. (b) Construction of a recombinant adenoviral genome containing DsRed
cassette. The DsRed cassette was transferred to the adenoviral vector by standard MAGIC procedure. The mixed bacteria were selected on LB plates containing
50 mgm l
 1 kanamycin,100 mgm l
 1ampicillin, 0.2% w/v L-arabinose and 10 mM Cl-Phe overnight. Plasmid DNA was isolated from 14 individual colonies. All
plasmid DNAs were digested with SalI and the digestion products were electrophoresed on 0.7% agarose gels and stained with ethidium bromide. Expected
restriction patterns for both pAd-DsRed (1–14, for each independently obtained plasmid) and pAd-pheS are shown opposite the gel.
Figure 2. The PCR product of a foreign gene was amplified by T4 DNA
polymerase and dGTP, and then was ligated with the Bsu36I-digested
pRTRA. The ligation mixture was transformed to the donor strain DH10b, and
then the recombinant donor plasmid was obtained. We introduced the two
different Bsu36I sites (CCTTAGG and CCTGAGG) in the pRTRA vector and
the 4 nt TTAC(50–30) in the forward primer and the other 4 nt TGAC
(50–30) in the reverse primer. The complete digestion of pRTRA with Bsu36I
results in a linearized donor vector with overhang ends of 50-TTA-30 and
50-TCA-30, respectively. We made use of the 30!50 exonuclease activity
and 50!30 polymerase activity of T4 DNA polymerase. When T4 DNA
polymerase encounters the first Guanine nucleotide at the 50 end of the DNA
in the dGTP bath, the reaction will keep the balance between the exonuclease
activity and polymerase activity. Therefore, the overhang ends of the gene
fragments of interest will be digested to be perfectly compatible with the
vector.
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tion, and the viruses were liberated by three freeze/thaw cycles.
T h ec e l ll y s a t e[ 1m li n1 · phosphate-buffered saline (PBS)
(pH 7.4)] containing the recombinant adenoviruses was then
ampliﬁed and puriﬁed. To generate higher titer viral stocks,
the HEK 293 cells were infected by the cell lysate and the har-
vest process was repeated.
Construction of a model adenoviral cDNA
expression library
The donor strain containing pRTRA and the donor strain con-
taining pRTGA were mixed at ratios of 1:30, 1:300, 1:3000
and 1:30 000 on the basis of their A600. The mixed donor
stains at different ratios were mixed with the recipient strain
at a 1:1 ratio on the basis of their A600 (3,18). The subsequent
experiments were based on the complete MAGIC procedure
as reported previously (18). LB broth was used to wash
all the colonies on the selective plates which were then incub-
ated overnight in 100 ml LB broth containing 50 mg/ml
kanamycin, 100 mg/ml ampicillin, 0.2% w/v L-arabinose
and 10 mM Cl-Phe. The DNA was extracted for greater
yields, treated with PacI, and the excess buffer and enzyme
were removed by phenol extraction/ethanol precipitation.
The DNA (5 mg) was re-suspended in 100 ml of sterile 0.1·
TE buffer or dH2O, and then added to a 60 mm plate contain-
ing 1 · 10
6 HEK293 cells that had been incubated in DMEM
with 5% FCS for 2 h. At 4 h post-transfection, the cells were
incubated for 8 days in 5 ml DMEM containing 5% FCS.
After three freeze-thaw cycles, the resultant lysate (1 ml)
was used to infect HEK 293 cells in a 10 cm plate (70% con-
ﬂuent) for 1 h before being incubated with 5 ml DMEM
supplemented with 5% FCS.
RESULTS
Construction of the donor vector pRTRA
As illustrated in Figure 1a, the donor vector pRTRA consists
of four elements: R (R6kori), T (oriT), R [DsRed cassette
[cmv-red-sv40poly(A)] and A (ampicillin resistance gene).
The DsRed cassette (cmv-Bsu36I-red-Bsu36I-sv40) was
obtained from pShuttle-cmv-red-sv40pol(A) by PCR. The
forward primer was 50-TTTGGTACCTTTTAGGGATAAC-
AGGGTAATTTTATCGATCGCGGGAAAACTGAATAAG-
AGGA-30(KpnI, I-SceI and ClaI sites underlined), the reverse
primer was 50-TTTGTCGACTTTGGCGCGCCCCCCACCT-
TATATATTCTTTCCCAC-30(SalI and AscI sites underlined).
The ampicillin resistance gene was obtained from pAdeasy by
PCR. The forward primer was TTTGTCGACCCTTT-
GATCTTTTCTACGGGGTCTGA (SalI site underlined), and
the reverse primer was TTTGAGCTCTTTTAGGGATAA-
CAGGGTAATAAATGTGCGCGGAACCCCTAT (SacI and
I-SceI sites underlined). The ampliﬁed fragments of the
DsRed cassette and ampicillin resistance gene were digested
with SalI, ligated and then ampliﬁed by PCR. The fragments
R6kori and oriT were cut down together with ApaI and
BstBI from the pMAGIC1. The cmv-red-sv40 pol(A)-amp
fragment and R6kori-oriT fragment were blunted, ligated and
transformed to generate the donor plasmid pRTRA.
Construction of recipient vector pAd-pheS
We ampliﬁed a fragment of kanamycin resistance gene that
needs to be added with I-SceI sites and 50 bp regions of homo-
logy in the primers. The I-SceI site was internal, and the 50 bp
regions of homology were external. The 50 bp regions of
homology included one upstream of the CMV promoter
(cmv-red-sv40polA) and the other downstream of the ampicil-
lin gene. The forward primer was 50-TTTCTCGAGGAA-
TAAGAGGAAGTGAAATCTGAATAATTTTGTGTTACT-
CATAGCGCGTAATAGGGATAACAGGGTAATCCGCTT-
GGGTGGAGAGGCTATT-30 (XhoI and I-SceI sites
underlined, 50 bp between the sites), and the reverse
primer was 50-TTTGTCGACTATTTTTCTAAATACAT-
TCAAATAGTATCCGCTCATGAGACAATAACCCTAGG-
GATAACAGGGTAATCAAACTGGAACAACACTCAAC-
CC-30 (SalI and I-SceI underlined, 50 bp between the sites).
Figure 3. The procedures for generating recombinant adenoviruses through
MAGIC. The donor and recipient plasmids were generated as described in the
text, then transformed into the donor strain A(DH10b) and recipient strain
B(BUN21). The DNA fragments of interest in the donor vector and the
negative marker (pheS) in the recipient vector were both cut down by an
intron-encoding rare endonuclease I-SceI, and then the recombination events
intermediated by the red and gam recombinase were stimulated. The
recombinant adenoviral plasmid was then generated. Restriction digestion
by PacI and subsequent transfection into HEK293 cell lines yielded a high
population of recombinant adenoviral particles after 7–10 day growth period.
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SalI was then ligated into the pShuttle vector, resulting in the
recombinant plasmid pShuttleK. A pheS Gly294 gene (1.3 kb
fragment derived from p1202) was ligated into the pShuttleK
(also double cut by the I-SceI enzyme). The recombinant
plasmid pShuttle-pheS was completely digested with PmeI,
and then treated with alkaline phosphatase. It was trans-
formed into E.coli BJ5183 (containing the adenovirus bone
vector pAdeasy) to produce the recombinant adenoviral plas-
mid (pShuttle vector plus gene of interest recombined with
pAdeasy). The resultant recombinant adenoviral plasmid
pAd-pheS was transformed into the recipient strain BUN21.
Modification of the donor plasmid pRTRA and
excision of the resistant gene
As the size of the foreign fragment is limited to 7.5 kb in the
Adeasy system, when a large fragment is required to be inser-
ted into the recipient plasmid, the existence of the amp gene
will take up the capacity of adenoviruses, limiting the size of
the foreign fragments. In addition, the biosafety concerns that
the amp gene may cause a spread of antibiotic resistance,
hamper the application of the recombinant adenovirus in
gene therapy. To avoid this problem, pRTRC, a modiﬁed
form of pRTRA, was constructed. The Cm cassette was
ﬂanked by 34 nt loxP sites for subsequent excision of the anti-
biotic cassette by Cre recombinase. For example, 10 mgo f
recombinant plasmids was mixed with 20 U of Cre recom-
binase in 300 ml of the reaction mixture at 37 C for 3 h
(data not shown). If the recombinant adenoviruses are used
as tools for protein expression in laboratory research, the
excision procedure may be unnecessary.
Recombination cloning efficiency of the MAGIC
strategy in adenoviral vectors
On the representative plates, we observed 300–400 colonies
per 1 ml mixture. Colonies selected for ampicillin were all
homologous recombinants. The presence of arabinose and
Cl-phe could eliminate the parental recipient plasmids (18).
The pheS Gly294 gene was 1.3 kb, and the ampicillin resist-
ance gene was 1.1 kb. We examined them further by using
multiple restriction digestions. The parental recipient plasmid
would be cut down to a 1.3 kb fragment (pheS gene), while
the recombinant plasmid would be cut down to a 1.1 kb frag-
ment (Amp gene). All of the screened colonies were only cut
down to a 1.1 kb fragment, demonstrating that 100% of the
screened clones contained only the desired recombination
construct (Figure 1b), which indicates that there is no need
to identify recombinants. Therefore, this method for recom-
binant adenoviral construction is highly efﬁcient which war-
rants no need for further identiﬁcation.
Expression of target genes in mammalian cells
The gfp, man and DsRed genes have been cloned into the
adenoviral bone vector pAd-pheS. Eight positive single
clones for each gene were picked up to incubate for recom-
binant DNAs to be transfected into the HEK293 cells. Fluor-
escence expression for each sample was detected using the
Leica TCS-SPII confocal system (Leica). The expression of
mannanase was detected in the agar plates supplemented
with 0.5% konjak mannan powder (stocked in this laboratory),
and 0.02% trypan blue (Sigma). The 10 ml supernatant of
HEK293 cells transfected with the recombinant adenoviral
plasmids was blotted on the plate at 37 C for 10 h to assess
the expression of mannanase. The supernatant of HEK293
cells transfected with the parental plasmids and the wild-
type adenoviruses were used as controls (data not shown).
All of the screened clones constructed through MAGIC
contained the correct construct (Figure 4).
Construction of an adenoviral cDNA expression library
in a model experiment
In a small-scale pilot experiment, we were able to demon-
strate the potential complexity generated in the AdLibrary
as constructed by MAGIC (Figure 5). Two donor bacteria,
which were identical except for the transgene expressed
(GFP and DsRed) and formed a donor library, were mixed
and converted to recipient bacteria simultaneously. A dilution
series was made, and the two donor bacteria were mixed at
four ratios; 1:30, 1:300, 1:3000 and 1:30000 (3). The
bacteria-based donor library containing a test DsRed at an
abundance of about 0.003% could be successfully converted
to the recipient strain to form a randomly desired DNA
expression adenoviral genome library (3). We could observe
the red ﬂuorescence protein expression in HEK293 cells at all
ratios (Table 1), even at the dilution of 1:30 000, which sug-
gests that a donor cDNA library can be efﬁciently converted
into an adenoviral library with a fair coverage of cDNAs rep-
resented in the donor bacteria-based library. In HEK293 cells,
the expression of red ﬂuorescence protein was detectable up
to the ratio of 1:30000, suggesting that this library can rep-
resent almost all the mRNA species present in the original
cells and the complexity of the library required could be
achieved (3,13). A donor bacteria-based cDNA expression
library must be initially constructed by the conventional
method and then mated with the recipient strain containing
the recipient plasmid, which leads to a successful construc-
tion of a bacteria-based cDNA adenoviral expression library.
The results indicate that the simple method for construction
of recombinant adenoviruses through MAGIC is also easily
adapted to the challenge of generating libraries (Figure 5).
Therefore, the method that constructs adenoviral cDNA
expression libraries effectively may offer a practical way
to facilitate the identiﬁcation of genes based on speciﬁc
biological functions for a variety of purposes.
DISCUSSION
Following the completion of the Human Genome Project and
the signiﬁcant progress made in identifying disease-causing
genes, an increasing need arises for the development of
high-throughput adenovirus production for various researches
and development projects. Traditional methods of construct-
ing recombinant adenoviruses cannot meet these ever-
growing needs. More recently, the site-speciﬁc recombination
of an expression cassette into the adenovirus genome to gen-
erate recombinant adenoviruses in E.coli has become popular.
This method is rapid since it eliminates the numerous
manipulations of sub cloning in vitro and multiple rounds
of plaque puriﬁcation.
In this study, we described a novel, simple and efﬁcient
method for the construction of recombinant adenovirus. As
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three major steps. First, the gene of interest is cloned into a
donor vector pRTRA. Second, the donor and the recipient
bacteria are mixed for mating, and the recombinants are selec-
ted by using kanamycin, ampicillin and Cl-Phe. Multiple
restriction digestion analysis is performed for further identi-
ﬁcation. Third, the recombinant adenoviral plasmid is cleaved
with PacI to expose its inverted terminal repeats and then
transfected into a packaging cell line (e.g. HEK 293 cells).
The positive selection by antibiotics, the negative selection
by Cl-Phe and the ability to bypass further identiﬁcation
steps make the screening of recombinants simple and efﬁcient.
To our knowledge, the method described herein is the ﬁrst
successful example to apply MAGIC to the construction of
recombinant adenoviruses. For adenoviral vector construc-
tion, this method has several advantages over other conven-
tional methods. First, a small size plasmid (3.5 kb) is used,
obviating the manipulation of the large adenoviral genome.
Second, the recombination events depend on a l red and
gam recombinase-mediated cassette exchange in E.coli, elim-
inating multiple repeated rounds of plaque puriﬁcation. Third,
the efﬁciency of the recombination can reach 100% since the
red and gam recombination system is highly efﬁcient and the
recombinants are selected by both arabinose and Cl-Phe
(18,21). This efﬁciency was further demonstrated in con-
structing an adenoviral cDNA expression library. Fourth,
the system has potential for the modiﬁcation of any adenov-
iral sequences (22). Therefore, the approach described here is
a highly efﬁcient, less time-consuming and labor-intensive
method for constructing recombinant adenoviruses. In addi-
tion, we speculate that the method can also be useful in the
construction of other viruses.
Many standard recombinant adenoviral vector systems
have been established, including Adeasy  and adenoviral
vector system based on Cre-lox (15,17). Compared with the
original system (the Adeasy  adenoviral vector system)
(15), we have improved the design and the implementation
of vector systems in three ways. First, in the Adeasy system,
the recombinant adenoviral plasmid cannot be effectively
ampliﬁed in the recombinant strain BJ5183, so it is necessary
to transform the recombinant plasmid to a recA, endA strain,
(such as DH10B, XL-Gold). In contrast, for the MAGIC
system, the desired recombinant adenoviral plasmid can be
achieved in the recipient strain with greater yields. Second,
in the Adeasy system, the pShuttle plasmid carries a
foreign gene, rendering the treatment with PmeI and
alkaline phosphatase necessary, which is not needed in the
MAGIC procedure. Third, the MAGIC method is much
more efﬁcient than the Adeasy system, and it can save
2–3 days in constructing recombinant Adenoviruses. The
high efﬁciency is attributable to that the combination via
the Red system is 500–1000 times more efﬁcient than the
BJ5183 platform (15), that inducing I-SceI also results in a
20-fold enrichment for recombinants, and that an additional
25-fold enrichment can be achieved by pheS. More recently,
a new method called recombinase-mediated cassette
exchange based on Cre-lox recombination in mammalian
cells has been reported, which needs several repeated
rounds of vector puriﬁcation and suffers from frequent
contamination of the replication-competent adenoviruses
(16). Although the rest of this method is rapid and simple,
the laborious manipulation of vector puriﬁcation will remark-
ably limit the applications of this elegant system.
In conclusion, we have described a robust approach for the
construction of recombinant adenoviruses based on
MAGIC and the Adeasy  adenoviral vector system, and it
yields the desired recombinant adenoviral genome 100% of
the time with high yields. The resulting plasmid containing
the recombinant adenoviral genome is truly clonal, obviating
the need for screening and several repeated rounds of plaque
puriﬁcation. Using this improved system based on MAGIC, a
set of hundreds or even thousands of recombinant adenoviral
Figure 4. PacI-digested pAdeasy-GFP and pAdeasy-DsRed were transfected separately into 293 cells. After 8 days, the recombinant adenoviruses were harvested
and then used to infect HEK293 cells. Adenovirus-producing foci and the fluorescence expression were detected using Leica TCS-SPII confocal system (Leica)
at 3–4 days post-infection.
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donor bacteria. Therefore, the method is compatible with
high-throughput applications including the construction of
cDNA expression library. Unlike conventional in vitro
methods that use restriction enzymes or site-speciﬁc recom-
binases, recombinant adenoviral DNA assembled by
MAGIC achieves a seamless transfer of genetic elements
through homologous recombination in vivo without the
need for DNA preparation and in vitro manipulation. More-
over, the highly efﬁcient l Red system will be of great use
for the knockout or modiﬁcation of other adenoviral
sequences (21,22). This robust, scalable and highly efﬁcient
method of constructing recombinant adenoviruses will be of
great use in genomics and proteomics researches.
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Figure 5. Experimental design of dilution experiments to demonstrate MAGIC can be used to construct an adenoviral cDNA expression library. The donor strain
containing the plasmid pRTGT was mixed with the donor strain containing the pRTRA at various ratios, and then the mixture was combined with the recipient
strain containing the recipient plasmid pAd-pheS. The mixed adenoviral plasmids containing pAd-GFP and pAd-DsRed were extracted and transfected into the
HEK293 cells. After 2–3 days, the green and red fluorescence expression was detected. The ratios of donor strain containing pRTRA mixed with donor strain
containing pRTGA were 1:30, 1:300, 1:3000 and 1:30 000, each marked with A, B, C and D, respectively. The quantities of the cells which can be observed with
red fluorescence expression are consistent with the ratios.
Table 1. pAd-DsRed representation shows the ratio of pAd-DsRed to
pAd-GFP, comprising the Ad5 genome used to convert to adenoviruses
pAd-DsRed representation DsRed-positive cells
1/30 >2000
1/300 1000
1/3000 200
1/30000 15
DsRed-positive cells show the number of Red-positive per plate for each dilu-
tion point.
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